Corporate calendar for Pulmonx Corporation (LUNG): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company also provides the Chartis Pulmonary Assessment System.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-16 | $1.28 | $8.32B |
| 2026-09-16 | $9M | |
| 2026-09-16 | ||
| 2026-09-16 | $-3.22 | $9M |
| 2026-09-16 | $-0.07 | $51M |
| 2026-09-16 | $-1.99 | $12M |
Price
| Price | $2.07 |
| Market Cap | $87M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ACRV · ASRT · EDAP · HYPR · IMUX · PMVP · RLMD
Explore sector: Healthcare · Medical - Devices
More sections of LUNG: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks